Exploring the Pharmacokinetic Profiles and Therapeutic Efficacy of Novel Drug Delivery Systems for Targeted Cancer Therapy
Abstract
Novel drug delivery systems developed for targeted cancer therapy are the focus of this investigation of their therapeutic efficacy and pharmacokinetic properties. Systemic toxicity and less-than-ideal results are common results of conventional cancer treatments because of their lack of selectivity. This study intends to better understanding of the interplay between different drug delivery mechanisms, their effects on drug distribution, and treatment results by investigating these systems within the body. Some of the goals include finding ways to improve targeted treatment and analyzing pharmacokinetic properties and therapeutic efficacy. Based on the results, it seems that there are drug delivery systems that have better therapeutic results and more favorable pharmacokinetic profiles than the traditional methods. Some of the suggestions include conducting additional studies to determine the best attributes of the distribution method and to confirm its effectiveness through clinical trials. With their enhanced effectiveness and decreased toxicity, personalized drug delivery systems have the ability to transform targeted cancer treatment, according to this research.
Keywords:
Pharmacokinetics, drug delivery systems, targeted therapy, cancer treatment, therapeutic efficacy, Novel Drug.
Prepared by the researcher:
sultan Mohammed Al gethami
Farah adnan alwohabe
Fayez raja almotiri
Zahra Abdulmohsan Aldijani